Vitiligo is an autoimmune skin condition causing depigmented patches due to destruction of melanocytes. It can affect any area of the body; treatment options include topical corticosteroids, phototherapy, and JAK inhibitors (ruxolitinib cream).
Dermatological and allergic conditions generate complications through chronic skin barrier dysfunction, immune dysregulation, infection susceptibility, psychological impact, and in the case of severe allergic reactions, life-threatening anaphylaxis. While many skin conditions are primarily cosmetic in impact, the barrier breakdown in conditions like eczema creates a portal for bacterial and viral skin infections. Systemic inflammatory conditions like severe psoriasis carry significant cardiovascular and metabolic comorbidities. Anaphylaxis represents the most dangerous acute complication across the allergic disease spectrum.
Immediate clinical action required
The following signs may indicate a new or worsening complication requiring prompt clinical evaluation:
Treatment & Management
Evidence-based treatment pathway, medications, and escalation criteria
Prognosis & Outlook
Long-term clinical outlook, improving and worsening outcome factors
Differential Diagnosis
Conditions that mimic Vitiligo — distinguishing features & tests
Vitiligo Overview
Symptoms, causes, and general condition overview
These conditions share overlapping symptoms with Vitiligo but have distinct complication patterns — understanding the differences is clinically important.
Describe your symptoms and get a structured clinical assessment — possible causes, red flags, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: